Cite
MLA Citation
X. D. Luo et al.. “Comparison of 208‐week sequential therapy with telbivudine and entecavir in HBeAg‐positive chronic hepatitis B patients with suboptimal responses to 24 weeks of Peg‐IFNα‐2a therapy: An open‐labelled, randomized, controlled, "real‐life" trial.” Journal of viral hepatitis, vol. 24, n.d., pp. 36–42. http://access.bl.uk/ark:/81055/vdc_100052194102.0x000033